Literature DB >> 15665816

Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1.

B H Huang1, M Laban, C H-W Leung, L Lee, C K Lee, M Salto-Tellez, G C Raju, S C Hooi.   

Abstract

Histone deacetylases (HDACs) 1 and 2 share a high degree of homology and coexist within the same protein complexes. Despite their close association, each possesses unique functions. We show that the upregulation of HDAC2 in colorectal cancer occurred early at the polyp stage, was more robust and occurred more frequently than HDAC1. Similarly, while the expression of HDACs1 and 2 were increased in cervical dysplasia and invasive carcinoma, HDAC2 expression showed a clear demarcation of high-intensity staining at the transition region of dysplasia compared to HDAC1. Upon HDAC2 knockdown, cells displayed an increased number of cellular extensions reminiscent of cell differentiation. There was also an increase in apoptosis, associated with increased p21Cip1/WAF1 expression that was independent of p53. These results suggest that HDACs, especially HDAC2, are important enzymes involved in the early events of carcinogenesis, making them candidate markers for tumor progression and targets for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665816     DOI: 10.1038/sj.cdd.4401567

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  107 in total

1.  VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin.

Authors:  Lei Zhang; Guiying Wang; Lin Wang; Chenlin Song; Ye Leng; Xinhua Wang; Jiuhong Kang
Journal:  Mol Cell Biochem       Date:  2011-09-30       Impact factor: 3.396

Review 2.  Targeting DNA repair in cancer: current state and novel approaches.

Authors:  Apostolos Klinakis; Dimitris Karagiannis; Theodoros Rampias
Journal:  Cell Mol Life Sci       Date:  2019-10-14       Impact factor: 9.261

Review 3.  Dietary manipulation of histone structure and function.

Authors:  Barbara Delage; Roderick H Dashwood
Journal:  Annu Rev Nutr       Date:  2008       Impact factor: 11.848

4.  A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

Authors:  Theodoros N Teknos; J Grecula; A Agrawal; M O Old; E Ozer; R Carrau; S Kang; J Rocco; D Blakaj; V Diavolitsis; B Kumar; P Kumar; Q Pan; M Palettas; L Wei; R Baiocchi; P Savvides
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

5.  Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis.

Authors:  Jennifer Jurkin; Gordin Zupkovitz; Sabine Lagger; Reinhard Grausenburger; Astrid Hagelkruys; Lukas Kenner; Christian Seiser
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

6.  Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.

Authors:  Durgadevi Ravillah; Altaf Mohammed; Li Qian; Misty Brewer; Yuting Zhang; Laura Biddick; Vernon E Steele; Chinthalapally V Rao
Journal:  J Pharmacol Exp Ther       Date:  2013-11-11       Impact factor: 4.030

7.  Role for histone deacetylase 1 in human tumor cell proliferation.

Authors:  Silvia Senese; Katrin Zaragoza; Simone Minardi; Ivan Muradore; Simona Ronzoni; Alfonso Passafaro; Loris Bernard; Giulio F Draetta; Myriam Alcalay; Christian Seiser; Susanna Chiocca
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

8.  Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity.

Authors:  Yingjie Zhang; Chunxi Liu; C James Chou; Xuejian Wang; Yuping Jia; Wenfang Xu
Journal:  Chem Biol Drug Des       Date:  2013-07-01       Impact factor: 2.817

9.  Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment.

Authors:  Zhenhua Lin; Martina Bazzaro; Mei-Cheng Wang; Kwun C Chan; Shiwen Peng; Richard B S Roden
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

10.  Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma.

Authors:  Xilin Du; Huadong Zhao; Li Zang; Nuan Song; Tao Yang; Rui Dong; Jikai Yin; Chengguo Wang; Jianguo Lu
Journal:  Pathol Oncol Res       Date:  2012-12-16       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.